Corporate Shogun
- Intent: A vaccine for the Blackwing Virus.
- Image Source: Artist Credit
- Canon Link: Not Applicable
- Permissions: Not Applicable
- Primary Source: Not Applicable
- Manufacturer: Nakaioma Medical
- Affiliation:
- Market Status: Closed-Market
- Model: Not Applicable
- Modularity: Not Applicable
- Production: Mass-Produced
- Material:
- Aerosol Combined Virus Cells
- Aerosol Container Unit
- Synthmesh Applicator Pen
- Classification: Drug
- Method of Consumption: Inhalation, 4 Doses Required
- Average Life: Indefinite
- Nutritional Value/Allergies/Side Effects/ Purpose: Vaccination for Blackwing virus, side effects may include sore throat, mild fever.
- Blackwing Immunity: Granting patients with immunity to what could possibly be one of the most aggressive and lethal diseases in the galaxy, the I71A Vaccine fulfils its intended purpose. Once all doses have been administered, immunity can be assured.
- Weak Side Effects: Whereas other reported anti-virus' developed in centuries past have retained the extremely painful symptoms of the Blackwing Virus, the I71A Vaccine, given its overly cautious development life cycle and procedures in developing it, has managed to contain side effects to mild fevers and sore throats only.
- Both Vectors Covered: As the Blackwing Virus spreads by two major vectors, airborne and via transmission of fluids, both of these were taken into account during the development of the vaccine, and after extensive testing, a final product of it-- capable of immunizing patients from both the airborne strain as well as against bites-- was completed.
- Four Doses: Using a live-variant of the Blackwing Virus, no matter how small or 'tamed' the sample would be, is far too dangerous. As such, an incredibly broken down, fragmented and dead variant of the virus has been used in its place. Though still able to provide immunity, the I71A Vaccine requires four doses over the course of two months in-order to be effective. At least a week between doses is recommended.
An immeasurably lethal and aggressive disease, Imperial Bioweapons Project I71A, otherwise known as the 'Blackwing Virus' has over numerous millennia been the catalyst for horrific tragedies. Developed by Nakaioma Medical Biotechnologies division, the 17-A Vaccine proved incredibly difficult to finish, with several accounts of test subjects attempting to break free from their quarantine, before being [REDACTED] by on-site security forces, whom had been ordered to the secretive facility en-masse. Over the course of the vaccine's production, a number of disturbing findings made by the development team, one of which being the virus' apparent [REDACTED], and its related origins in [REDACTED], would lead to the project being re-designated to the corporation's highest security, quarantine and classified levels. Extracting samples of the virus from infected individuals on [REDACTED], the project was undertaken at [REDACTED], while the research and development team had been led by [REDACTED]. Recommendations made by the team following the completion of the vaccine include the immediate destruction of all I71A samples held by Nakaioma Medical.
Spread by two primary vectors, airborne and through transmission of fluids, typically via biting (the preferred method of infected individuals), and with an infection rate of almost 100%, the I71A Vaccine took abnormally long to develop. Manufactured by introducing the virus to uninfected test subjects, acquired from various sources, the vaccine was synthesized by enriching the virus within the lungs of human hosts, before destroying it with concentrated doses of engineered antibodies. The remnants of these dead viral cells would later be extracted and extensively observed, and even kept in a quarantine of their own, despite presumably being inactive, given the unnaturally hostile and intelligent nature of the disease. Once confirmed to be dead, the cells would further again be broken down with targeted anti-virus attacks, chipping away at them until only tiny fragments of them remained. At this point the fragments would be separated, each containing a distinct element of the virus and studied independently of one another, before synthetic replicants of each fragment were created, and recombined into one dead cell again.
This incredibly complex, time-consuming and costly method was necessary to prevent infection due to the insidious nature of the virus, at least half a dozen times it had attempted to reactivate itself when under study, a number of staff members had almost been infected, even when equipped with state-of-the-art biohazard equipment, and the infected test subjects themselves displayed extraordinary amounts of intelligence and logical thinking. Being noted to have seemingly been observing guard patterns, and structural weak points within their containments in their various attempts to break free. Due to the dozen times over killed and picked apart nature of the virus cells used in the vaccine, at least four doses will be required over the span of two months for full immunity to be granted, in theory this could be achieved in a lesser amount of time, but for safety precautions, Nakaioma Medical has issued a strong advisory to any and all clients that two months is the safest amount of time that four doses can be taken, without diluting its immunizing effects too much. Fortunately, once all doses have been administered, immunity is guaranteed, and side-effects are restricted to mild fevers and sore throats. The vaccine is administered via aerosol injection into the nostrils.
Last edited:
